| Literature DB >> 24619425 |
Yuefeng Sun1, Ravi Kasiappan, Jinfu Tang, Panida L Webb, Waise Quarni, Xiaohong Zhang, Wenlong Bai.
Abstract
Fe65 is a multidomain adaptor with established functions in neuronal cells and neurodegeneration diseases. It binds to the C terminus of the Aβ amyloid precursor protein and is involved in regulating gene transcription. The present studies show that Fe65 is expressed in breast cancer (BCa) cells and acts as an ERα transcriptional coregulator that is recruited by 17β-estradiol to the promoters of estrogen target genes. Deletion analyses mapped the ERα binding domain to the phosphotyrosine binding domain 2 (PTB2). Ectopic Fe65 increased the transcriptional activity of the ERα in a PTB2-dependent manner in reporter assays. Fe65 knockdown decreased, whereas its stable expression increased the transcriptional activity of endogenous ERα in BCa cells and the ability of estrogens to stimulate target gene expression, ERα, and coactivator recruitment to target gene promoters and cell growth. Furthermore, Fe65 expression decreased the antagonistic activity of tamoxifen (TAM), suggesting a role for Fe65 in TAM resistance. Overall, the studies define a novel role for the neuronal adaptor in estrogen actions in BCa cells.Entities:
Keywords: Breast Cancer, Estrogens, Estrogen Receptor, Fe65, Tamoxifen; Cancer Biology; Cell Growth; DNA Transcription; Endocrinology; Gene Transcription; Hormone Receptors; Hormones; Nuclear Receptors
Mesh:
Substances:
Year: 2014 PMID: 24619425 PMCID: PMC4007422 DOI: 10.1074/jbc.M113.526194
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157